RG004
RSV Vaccine
Preclinical (IND granted per timeline)Active
Key Facts
Indication
RSV Vaccine
Phase
Preclinical (IND granted per timeline)
Status
Active
Company
About RinuaGene Biotechnology
A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.
View full company profile